This Tech Company Is a Top AI Stock on Robinhood. I Still Can't Convince Myself to Buy It.

Palantir’s stock is up 1,600% over three years, while sales have risen from $1.9 billion in 2022 to nearly $4.5 billion in 2025 and net income increased to $1.6 billion from a $373 million loss. The article argues the shares are too expensive at a 113x forward P/E, despite bullish analyst coverage and an average price target around $186 versus about $146 currently. The piece is fundamentally a valuation critique rather than a new business update.

Analysis

PLTR’s setup is increasingly classic late-cycle momentum: the business keeps compounding, but the stock’s duration has stretched so far that any deceleration in billings, net retention, or government procurement cadence could trigger a sharp multiple reset. The key second-order effect is that a rising-share-price story can become self-reinforcing through retail and systematic flows, but that same ownership base is fragile if the tape turns—meaning downside can air-pocket on seemingly modest operational misses.

The bigger market implication is not that PLTR is “bad,” but that it is now a barometer for AI infrastructure monetization outside the obvious beneficiaries. If investors decide PLTR’s premium is unsustainable, capital is likely to rotate toward cheaper AI toll-takers with clearer hardware or workload bottlenecks, especially NVDA and INTC. That favors names where demand is still constrained by capacity or product cycle rather than by valuation alone.

Contrarianly, the consensus may be underestimating how sticky enterprise and government software can become once it is embedded in workflow and compliance, which supports multi-year revenue visibility. But the market likely already discounts a very optimistic path: sustained high-30s growth, margin stability, and no competitive encroachment. The risk is that even if fundamentals remain strong, the stock can underperform for months if it merely grows into the valuation rather than re-rating higher.

Near term, the catalyst path is asymmetric: any evidence of slower commercial conversion, smaller deal sizes, or softer forward guidance matters more than another headline growth print. Conversely, a fresh AI government contract or a visible acceleration in commercial adoption could support the stock, but probably not enough to justify materially higher entry points absent a broader multiple expansion regime.

Key Decisions for Investors

• Avoid initiating fresh long PLTR here; if already long, hedge with a 1-3 month collar or partial short-dated call overwrite to monetize elevated implied volatility while capping upside.
• Prefer a relative-value long NVDA / short PLTR pair over the next 1-2 quarters: NVDA has more direct AI capex linkage and less valuation risk from narrative fatigue; target mean reversion if PLTR’s multiple compresses while AI spend stays intact.
• Use PLTR weakness only on a post-earnings pullback below key support to consider tactical longs; risk/reward improves materially if the stock de-rates 15-20% while fundamentals remain intact.
• Overweight INTC as a delayed AI catch-up beneficiary if enterprise AI adoption broadens beyond software narratives; it offers a cheaper, less crowded way to express the same AI capex theme.
• If seeking a hedge against a PLTR momentum unwind, consider short PLTR against a basket of profitable AI infrastructure names (NVDA, MORN) for 2-6 months, since the likely loser in a valuation reset is the highest-duration software name.